The Validation of a Hemagglutination Inhibition Assay That Detects Antibodies Against a Newcastle Disease Virus-Based Vaccine Vector in Human Serum Samples
We conclude that the suitability of the analytical method for its intended use is confirmed, guaranteeing the reliability of the results obtained under the established operating conditions.
Authors
- Bernardo Lozano-Dubernard (ORCID: https://orcid.org/0009-0009-6430-7080)
- Horacio Zamudio‐Meza (ORCID: https://orcid.org/0000-0002-8456-2881)
- Martha Torres (ORCID: https://orcid.org/0000-0003-3217-9407)
- Luis Ramírez-Martínez (ORCID: https://orcid.org/0000-0002-9162-5721)
- Edgar Reyna-Rosas (ORCID: https://orcid.org/0000-0002-2476-3569)
- Claudia Carranza (ORCID: https://orcid.org/0000-0001-6226-6056)
- Milton Nieto-Ponce
- Rosa Andrea. Palencia-Reyes
- Carlos Blancas-Ruíz
- Guadalupe Aguilar-Rafael
- Marlenne Paola. Rubicer. Rubio-Diaz
Institutions
- Instituto Nacional de Enfermedades Respiratorias (MX)
Publication Details
- Journal
- Vaccines
- Published
- 2025-03-22
- DOI
- https://doi.org/10.3390/vaccines13040342
- Primary Topic
- Virology and Viral Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00